Eris Lifesciences Limited (BOM:540596)

Eris Lifesciences Revenue

Eris Lifesciences had revenue of 8.96B INR in the quarter ending September 30, 2026, with 13.34% growth. This brings the company's total for the last twelve months to 33.15B, up 11.01% year-over-year. In the fiscal year ending March 31, 2026, Eris Lifesciences had annual revenue of 31.15B with 8.18% growth.

• Revenue (ttm): 33.15B
• Revenue Growth: +11.01%
• P/S Ratio: 4.92
• Revenue / Employee: 12.02M
• Employees: 2,758
• Market Cap: 163.07B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• India 27.73B 89.0%
• outside India 3.42B 11.0%

Fiscal year ended Mar 31, 2026 See the full Eris Lifesciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	31.15B	2.36B	8.18%
Mar 31, 2025	28.79B	8.88B	44.59%
Mar 31, 2024	19.91B	3.29B	19.83%
Mar 31, 2023	16.62B	3.36B	25.31%
Mar 31, 2022	13.26B	1.34B	11.20%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error